HCPLive

Alcohol Ablations More Effective in Blocking Atrial Fibrillation than Standard Therapy

Atrial fibrillation can be treated by adding a little ethanol to minimally invasive therapies, according to a study published in the Journal of the American College of Cardiology.

By adding 4 or fewer injections of 98% ethanol to the catheter-aided radio wave ablation of nerve clusters near the vein of Marshall, the nerves triggering arrhythmia were damaged or killed. Doctors were then unable to artificially trigger atrial fibrillation using electricity, which is used to determine if ablations were successful.

“Radiofrequency ablation carries risks of collateral damage to other structures and there are also risks associated with surgical approaches,” Miguel Valderrábano, MD, chief of cardiac electrophysiology at Houston Methodist DeBakey Heart & Vascular Center, said in a press release. “We show that chemical ablation with alcohol can achieve elimination of abnormal nerve activity, introducing a catheter through a neck vein and doing all the work through it.”

Instead of current standard surgical therapy, a concentrated radio wave that causes tissues in small areas to burn and scar, the alcohol therapy appeared to be more effective. Additionally, the researchers hope that the alcohol ablations would improve effectiveness of standard therapies. Currently, patients sometimes need a second ablation months or years later. Valderrábano and others are investigating improvements to ablation procedures so they only need to be completed once.

Most Popular

Recommended Reading

A recent study looked into the neural functions affected by ibuprofen and found some connections that may soon lead to a much greater understanding of the greatest pain mitigator of them all: the brain.
Researchers from the University of California-Santa Barbara recently announced they have created an implantable “artificial pancreas” that could potentially eliminate the need for insulin injections and pumps for treating type 1 diabetes.
Discontinuation of multiple sclerosis medication saw nearly 2 in 5 patients experience some form of increased disease activity, according to research from NYU Langone Medical Center.
A novel virus from Peru and the Republic of Congo called enterovirus C105 is now suspected in last year's wave of mysterious cases of sudden childhood paralysis.
$vAR$